Skip to content

Effect of Acute Nitrate Supplementation on Vascular Function in Hispanic, Black and White Population

Effect of Acute Nitrate Supplementation on Vascular Function in Hispanic, Black and White Population

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05188079
Enrollment
90
Registered
2022-01-12
Start date
2021-10-01
Completion date
2028-01-31
Last updated
2025-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Brief summary

The purpose of the study is to assess vascular function in African Americans, Hispanic and Caucasian Americans to better understand racial differences in cardiovascular health. The investigators will further investigate the affect of Beetroot juice on the vascular function of all participants.

Detailed description

African Americans and Hispanic individuals have the highest incidence of type 2 diabetes, which increases their risk of all cardiovascular diseases. One of the hallmarks of type 2 diabetes is vascular dysfunction, caused by a lack of nitric oxide bioavailability. Vascular function and blood flow responses to exercise have been shown to improve after nitrate supplementation (beetroot juice), However, whether nitrate supplementation will improve vascular function in African American and Hispanic individuals remains unknown. The investigators will perform a randomized, placebo-controlled study in healthy African American, Hispanic and Caucasian subjects. They will be studied before and 90 minutes after consuming Beetroot juice (high nitrate supplement) or Placebo, with at least 1-week washout period between the two visits (Kenjale AA et al., J Appl Physiol 2011).

Interventions

DIETARY_SUPPLEMENTBeetroot juice

high nitrate supplement

DIETARY_SUPPLEMENTPlacebo drink

placebo

Sponsors

University of Texas at Austin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

it will be double blinded

Intervention model description

randomized, cross-over, placebo-controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy men and women who are either Caucasian American, Hispanic, or non-Hispanic African American

Exclusion criteria

* Blood pressure higher than or equal to 140/90 mmHg * BMI \> 35kg/m2 * Have a history of cardiovascular, neurological or vascular diseases * Take prescription medications * Are smokers * Are pregnant

Design outcomes

Primary

MeasureTime frameDescription
Forearm blood flowthrough study completion, an average of 2 yearBlood flow of the brachial artery will be measured continuously at rest, during 3 min of handgrip exercise and for up to 1 min after the cessation of handgrip exercise.

Secondary

MeasureTime frameDescription
Flow mediated vasodilationthrough study completion, an average of 2 yearThe subjects will lay supine with arm extended on a side table. Resting brachial artery diameter and velocity will be measured at rest for 2 min. Following this, a pneumatic cuff will be inflated on the forearm to supersystolic pressure (220-240 Torr) for 5 min and once the cuff is released, brachial artery diameter and velocity will be measured for up to 3 minutes after cuff deflation. FMD% will be calculated as (highest diameter after cuff deflation - baseline brachial artery diameter)/ baseline diameter \* 100

Countries

United States

Contacts

Primary Contactjasdeep kaur, PhD
jasdeep.kaur@austin.utexas.edu5124718595

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026